CR
Charles River Laboratories
🇺🇸XNYS.CRLUnited StatesHealthcare
$273.57USDup +0.96 (+0.35%)ClosedDelayed8:34 PM
Price$273.57+0.96 (+0.35%)
Profile
- Healthcare
- Diagnostics & Research
- United States
Identity
- Exchange
- New York Stock Exchange . XNYS
- Type
- Stock
- ISIN
- US1598641074
- CUSIP
- 159864107
Company
- Employees
- 18,300
- Headquarters
- Wilmington, United States
- Website
- https://www.criver.com
- CEO
- Ms. Birgit Girshick
Market
- Shares outstanding
- 48.2M
- Market cap
- $13.18B
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- $13.13B
- EPS LTM
- -$4.92
- P/E LTM
- -45.71
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $4B-0.74%down year on year
- Net income
- -$238.46M-244.47%down year on year
- Gross margin
- 32.24%-0.7%down year on year
- Free cash flow
- $370.61M-35.94%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.